Inventory Summary of Resverlogix Corp.

Resverlogix Corp.'s latest annual inventory in 2022 was 2.37 Million USD , down -3.34% from previous year.
Resverlogix Corp.'s latest quarterly inventory in 2023 Q3 was 2.37 Million USD , down 0.0% from previous quarter.
Resverlogix Corp. reported annual inventory of 2.45 Million USD in 2021, down 0.0% from previous year.
Resverlogix Corp. reported annual inventory of 1.55 Million USD in 2019, up 34.34% from previous year.
Resverlogix Corp. reported quarterly inventory of 2.37 Million USD for 2023 Q3, down 0.0% from previous quarter.
Resverlogix Corp. reported quarterly inventory of 2.42 Million USD for 2022 Q2, down 0.0% from previous quarter.

Annual Inventory Chart of Resverlogix Corp. (2022 - 2001)

Historical Annual Inventory of Resverlogix Corp. (2022 - 2001)

Year	Inventory	Inventory Growth
2022	2.37 Million USD	-3.34%
2021	2.45 Million USD	0.0%
2019	1.55 Million USD	34.34%
2018	1.15 Million USD	-62.17%
2017	3.05 Million USD	-8.59%
2016	3.34 Million USD	80.8%
2015	1.84 Million USD	474.22%
2014	322 Thousand USD	187.5%
2013	112 Thousand USD	-50.22%
2012	225 Thousand USD	-72.15%
2011	808 Thousand USD	-13.68%
2010	936 Thousand USD	67.58%
2009	558.53 Thousand USD	0.0%
2008	- USD	0.0%
2007	- USD	0.0%
2006	- USD	0.0%
2005	- USD	0.0%
2004	- USD	0.0%
2003	- USD	0.0%
2002	- USD	0.0%
2001	- USD	0.0%

Year	Inventory	Inventory Growth
2023 Q2	2.37 Million USD	0.0%
2023 Q3	2.37 Million USD	0.0%
2022 Q2	2.42 Million USD	0.0%
2022 Q3	2.38 Million USD	-1.81%
2022 FY	2.37 Million USD	-3.34%
2022 Q1	2.42 Million USD	-1.1%
2022 Q4	2.37 Million USD	-0.46%
2021 FY	2.45 Million USD	0.0%
2021 Q3	2.54 Million USD	310.99%
2021 Q4	2.45 Million USD	-3.58%
2021 Q2	619 Thousand USD	5.99%
2021 Q1	584 Thousand USD	0.0%
2020 Q3	1.16 Million USD	-4.11%
2020 Q1	1.55 Million USD	-48.8%
2020 Q2	1.21 Million USD	-21.57%
2019 FY	1.55 Million USD	34.34%
2019 Q4	3.03 Million USD	24.1%
2019 Q3	2.44 Million USD	78.52%
2019 Q1	1.15 Million USD	-45.21%
2019 Q2	1.36 Million USD	18.43%
2018 Q3	2.28 Million USD	-25.85%
2018 Q4	2.11 Million USD	-7.7%
2018 Q1	3.05 Million USD	25.61%
2018 Q2	3.08 Million USD	0.88%
2018 FY	1.15 Million USD	-62.17%
2017 Q1	3.34 Million USD	0.94%
2017 FY	3.05 Million USD	-8.59%
2017 Q4	2.43 Million USD	-19.33%
2017 Q2	2.96 Million USD	-11.46%
2017 Q3	3.01 Million USD	1.89%
2016 Q1	1.84 Million USD	-25.08%
2016 Q4	3.31 Million USD	-26.14%
2016 Q3	4.48 Million USD	162.53%
2016 Q2	1.7 Million USD	-7.63%
2016 FY	3.34 Million USD	80.8%
2015 Q3	2.04 Million USD	4.81%
2015 Q2	1.95 Million USD	506.52%
2015 FY	1.84 Million USD	474.22%
2015 Q1	322 Thousand USD	-1.83%
2015 Q4	2.46 Million USD	20.57%
2014 Q1	112 Thousand USD	-62.79%
2014 FY	322 Thousand USD	187.5%
2014 Q3	64 Thousand USD	-71.3%
2014 Q2	223 Thousand USD	99.11%
2014 Q4	328 Thousand USD	412.5%
2013 FY	112 Thousand USD	-50.22%
2013 Q1	225 Thousand USD	5.63%
2013 Q2	- USD	-100.0%
2013 Q3	- USD	0.0%
2013 Q4	301 Thousand USD	0.0%
2012 FY	225 Thousand USD	-72.15%
2012 Q1	808 Thousand USD	3.59%
2012 Q2	437 Thousand USD	-45.92%
2012 Q3	385 Thousand USD	-11.9%
2012 Q4	213 Thousand USD	-44.68%
2011 Q4	780 Thousand USD	-14.75%
2011 Q1	936 Thousand USD	-27.57%
2011 Q3	915 Thousand USD	-41.04%
2011 Q2	1.55 Million USD	65.81%
2011 FY	808 Thousand USD	-13.68%
2010 Q2	- USD	-100.0%
2010 Q4	1.29 Million USD	-1.68%
2010 Q1	558.53 Thousand USD	0.0%
2010 FY	936 Thousand USD	67.58%
2010 Q3	1.31 Million USD	0.0%
2009 Q3	- USD	0.0%
2009 FY	558.53 Thousand USD	0.0%
2009 Q4	- USD	0.0%
2009 Q2	- USD	0.0%
2009 Q1	- USD	0.0%
2008 FY	- USD	0.0%
2008 Q4	- USD	0.0%
2008 Q3	- USD	0.0%
2008 Q2	- USD	0.0%
2008 Q1	- USD	0.0%
2007 FY	- USD	0.0%
2007 Q4	- USD	0.0%
2007 Q2	- USD	0.0%
2007 Q1	- USD	0.0%
2007 Q3	- USD	0.0%
2006 Q2	- USD	0.0%
2006 Q1	- USD	0.0%
2006 FY	- USD	0.0%
2006 Q4	- USD	0.0%
2006 Q3	- USD	0.0%
2005 Q1	- USD	0.0%
2005 Q4	- USD	0.0%
2005 FY	- USD	0.0%
2005 Q2	- USD	0.0%
2005 Q3	- USD	0.0%
2004 Q1	- USD	0.0%
2004 FY	- USD	0.0%
2004 Q4	- USD	0.0%
2004 Q3	- USD	0.0%
2004 Q2	- USD	0.0%
2003 Q3	- USD	0.0%
2003 Q2	- USD	0.0%
2003 Q4	- USD	0.0%
2003 FY	- USD	0.0%
2003 Q1	- USD	0.0%
2002 Q3	- USD	0.0%
2002 Q4	- USD	0.0%
2002 Q1	- USD	0.0%
2002 Q2	- USD	0.0%
2002 FY	- USD	0.0%
2001 FY	- USD	0.0%

Peer Inventory Comparison of Resverlogix Corp.

Name	Inventory	Inventory Difference
Eiger BioPharmaceuticals, Inc.	1.55 Million USD	-52.378%
Nanobac Pharmaceuticals, Incorporated	10.3 Thousand USD	-22912.715%
SQZ Biotechnologies Company	- USD	-Infinity%
Evofem Biosciences, Inc.	1.69 Million USD	-39.717%
Santhera Pharmaceuticals Holding AG	2.15 Million USD	-10.228%
Mesoblast Limited	1.00 USD	-237099900.0%
Propanc Biopharma, Inc.	- USD	-Infinity%
Genus plc	89.4 Million USD	97.348%
VioQuest Pharmaceuticals, Inc.	- USD	-Infinity%
CNBX Pharmaceuticals Inc.	-94.61 Thousand USD	2606.025%
Marizyme, Inc.	24.85 Thousand USD	-9439.328%
ContraFect Corporation	- USD	-Infinity%
Nymox Pharmaceutical Corporation	16 Thousand USD	-14718.75%
PsyBio Therapeutics Corp.	- USD	-Infinity%
Sienna Biopharmaceuticals, Inc.	- USD	-Infinity%
RegeneRx Biopharmaceuticals, Inc.	- USD	-Infinity%
Intellipharmaceutics International Inc.	1.00 USD	-237099900.0%
AXIM Biotechnologies, Inc.	- USD	-Infinity%
MultiCell Technologies, Inc.	- USD	-Infinity%
Accustem Sciences Inc.	- USD	-Infinity%
RVL Pharmaceuticals plc	784 Thousand USD	-202.423%
EV Biologics, Inc.	- USD	-Infinity%
Q BioMed Inc.	- USD	-Infinity%
Emmaus Life Sciences, Inc.	1.71 Million USD	-38.574%
Neon Bloom, Inc.	7938.00 USD	-29768.985%
Mosaic ImmunoEngineering Inc.	- USD	-Infinity%
Biomind Labs Inc.	- USD	-Infinity%
TetraLogic Pharmaceuticals Corporation	- USD	-Infinity%
Pharming Group N.V.	56.76 Million USD	95.823%
Oncotelic Therapeutics, Inc.	- USD	-Infinity%
Skye Bioscience, Inc.	- USD	-Infinity%
Therapeutic Solutions International, Inc.	22.57 Thousand USD	-10403.234%
THC Farmaceuticals, Inc.	- USD	-Infinity%
Arch Therapeutics, Inc.	1.36 Million USD	-73.763%
IMV Inc.	2.00 USD	-118549900.0%
Acro Biomedical Co., Ltd.	12 Thousand USD	-19658.333%
Curative Biotechnology, Inc.	-115.62 Thousand USD	2150.595%
GB Sciences, Inc.	- USD	-Infinity%
Alpha Cognition Inc.	90.41 Thousand USD	-2522.41%
HST Global, Inc.	- USD	-Infinity%
CSL Limited	5.96 Billion USD	99.96%
Halberd Corporation	- USD	-Infinity%
Enzolytics Inc.	- USD	-Infinity%
Affymax, Inc.	- USD	-Infinity%
SYBLEU INC	- USD	-Infinity%
Nuo Therapeutics, Inc.	209.58 Thousand USD	-1031.262%
argenx SE	310.55 Million USD	99.237%
MetaStat, Inc.	- USD	-Infinity%
Northwest Biotherapeutics, Inc.	- USD	-Infinity%
Enzon Pharmaceuticals, Inc.	- USD	-Infinity%
Arno Therapeutics, Inc.	- USD	-Infinity%
RespireRx Pharmaceuticals Inc.	- USD	-Infinity%
GeneThera, Inc.	- USD	-Infinity%
Inhibitor Therapeutics, Inc.	- USD	-Infinity%
AVAX Technologies, Inc.	11.52 Thousand USD	-20481.597%
Zenith Capital Corp.	3.00 USD	-79033233.333%
Genscript Biotech Corporation	53.33 Million USD	95.554%
Ember Therapeutics, Inc.	- USD	-Infinity%
Anthera Pharmaceuticals, Inc.	- USD	-Infinity%
Sigyn Therapeutics, Inc.	50 Thousand USD	-4642.0%
WPD Pharmaceuticals Inc.	0.25 USD	-948399900.0%
American Oriental Bioengineering, Inc.	20.57 Million USD	88.474%
Provectus Biopharmaceuticals, Inc.	- USD	-Infinity%
Adynxx, Inc.	- USD	-Infinity%
Helix BioMedix, Inc.	- USD	-Infinity%
GlobeStar Therapeutics Corporation	- USD	-Infinity%
VitaSpring Biomedical Co. Ltd.	- USD	-Infinity%
Capstone Therapeutics Corp.	12.83 Million USD	81.531%
Cotinga Pharmaceuticals Inc.	0.98 USD	-241938675.51%
BioStem Technologies, Inc.	658.67 Thousand USD	-259.963%
ONE Bio Corp.	4.5 Million USD	47.372%
Reve Technologies, Inc.	- USD	-Infinity%
Burzynski Research Institute, Inc.	- USD	-Infinity%
Wesana Health Holdings Inc.	1.00 USD	-237099900.0%
Agentix Corp.	- USD	-Infinity%
LadRx Corporation	- USD	-Infinity%
Cell Source, Inc.	- USD	-Infinity%
ProtoKinetix, Incorporated	- USD	-Infinity%
Regen BioPharma, Inc.	- USD	-Infinity%
Regen BioPharma, Inc.	- USD	-Infinity%
NovAccess Global Inc.	- USD	-Infinity%
Endonovo Therapeutics, Inc.	- USD	-Infinity%
Itoco Inc.	- USD	-Infinity%
Rasna Therapeutics, Inc.	-20.67 Thousand USD	11570.176%
Pathfinder Cell Therapy, Inc.	- USD	-Infinity%
Kadimastem Ltd	- USD	-Infinity%
Oncology Pharma Inc.	- USD	-Infinity%
Institute of Biomedical Research Corp.	- USD	-Infinity%
CytoDyn Inc.	- USD	-Infinity%
Claritas Pharmaceuticals, Inc.	- USD	-Infinity%
NDT Pharmaceuticals Inc.	- USD	-Infinity%
Mobile Lads Corp.	- USD	-Infinity%
NanoSphere Health Sciences Inc.	-8.71 USD	27221684.386%
Qrons Inc.	- USD	-Infinity%
Alseres Pharmaceuticals, Inc.	- USD	-Infinity%
Advanced Proteome Therapeutics Corporation	- USD	-Infinity%
Nascent Biotech, Inc.	- USD	-Infinity%
Rebus Holdings, Inc.	- USD	-Infinity%
ImmunoCellular Therapeutics, Ltd.	- USD	-Infinity%
International Stem Cell Corporation	1.26 Million USD	-87.728%
Bioxytran, Inc.	- USD	-Infinity%
GlobeImmune, Inc.	- USD	-Infinity%
Predictive Technology Group, Inc.	- USD	-Infinity%
ProText Mobility, Inc.	15 Million USD	84.193%
Cardax, Inc.	- USD	-Infinity%
VG Life Sciences Inc.	- USD	-Infinity%
Kaleido Biosciences, Inc.	- USD	-Infinity%
Advaxis, Inc.	- USD	-Infinity%
Adhera Therapeutics, Inc.	- USD	-Infinity%
RenovaCare, Inc.	- USD	-Infinity%
Regnum Corp.	- USD	-Infinity%
Innovation Pharmaceuticals Inc.	- USD	-Infinity%
Neutra Corp.	- USD	-Infinity%
Windtree Therapeutics, Inc.	- USD	-Infinity%
PureTech Health plc	- USD	-Infinity%
Coeptis Therapeutics, Inc.	- USD	-Infinity%
IXICO plc	1.00 USD	-237099900.0%
IntelGenx Technologies Corp.	71 Thousand USD	-3239.437%
Gelesis Holdings, Inc.	6.86 Million USD	65.462%
CSL Limited	5.96 Billion USD	99.96%
Cellectis S.A.	1.00 USD	-237099900.0%

Global Stocks Search

Resverlogix Corp. (RVXCF)

Inventory Summary of Resverlogix Corp.

Annual Inventory Chart of Resverlogix Corp. (2022 - 2001)

Historical Annual Inventory of Resverlogix Corp. (2022 - 2001)

Peer Inventory Comparison of Resverlogix Corp.